Mohammed Milhem
Clinical trials sponsored by Mohammed Milhem, explained in plain language.
-
Selenium added to cancer drugs in new kidney cancer trial
Disease control OngoingThis study is testing whether adding a selenium supplement (Seleno-L Methionine) to two standard cancer drugs (axitinib and pembrolizumab) is safe and more effective for treating advanced kidney cancer. It will involve about 55 adults with a specific type of kidney cancer that ha…
Phase: PHASE1, PHASE2 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Early trial tests common bone drug against rare bone cancer
Disease control OngoingThis early-stage study is testing whether a drug called zoledronic acid, commonly used to strengthen bones, can help control tumor growth in patients with a rare bone cancer called chondrosarcoma. The drug is given once before surgery and once after, and researchers are checking …
Phase: PHASE1 • Sponsor: Mohammed Milhem • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC